1. Home
  2. PK vs WGS Comparison

PK vs WGS Comparison

Compare PK & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Park Hotels & Resorts Inc.

PK

Park Hotels & Resorts Inc.

SELL

Current Price

$15.59

Market Cap

3.1B

Sector

Real Estate

ML Signal

SELL

Logo GeneDx Holdings Corp.

WGS

GeneDx Holdings Corp.

HOLD

Current Price

$64.96

Market Cap

2.7B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
PK
WGS
Founded
1946
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Retail: Computer Software & Peripheral Equipment
Sector
Real Estate
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
2.7B
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
PK
WGS
Price
$15.59
$64.96
Analyst Decision
Hold
Strong Buy
Analyst Count
18
8
Target Price
$16.18
★ $93.50
AVG Volume (30 Days)
★ 3.2M
731.3K
Earning Date
11-04-2026
10-27-2026
Dividend Yield
★ 6.59%
N/A
EPS Growth
N/A
★ 62.37
EPS
★ 0.29
N/A
Revenue
★ $2,791,000,000.00
$427,539,000.00
Revenue This Year
N/A
$12.70
Revenue Next Year
$2.10
$24.31
P/E Ratio
$52.31
★ N/A
Revenue Growth
2.35
★ 39.97
52 Week Low
$9.84
$32.21
52 Week High
$16.20
$170.87

Technical Indicators

Market Signals
Indicator
PK
WGS
Relative Strength Index (RSI) 50.11 33.85
Support Level $14.45 $56.36
Resistance Level $15.48 $73.21
Average True Range (ATR) 0.38 5.42
MACD -0.02 -2.04
Stochastic Oscillator 38.54 10.60

Price Performance

Historical Comparison
PK
WGS

About PK Park Hotels & Resorts Inc.

Park Hotels & Resorts owns upper-upscale and luxury hotels, with 19,902 rooms across 29 hotels in the United States. Park also has an interest through a joint venture in another 1,424 rooms in another US hotel. Park was spun out of Hilton Worldwide Holdings at the start of 2017, so most of its hotels are still under the Hilton brand. The company has sold all its international hotels and many of its lower-quality US hotels to focus on high-quality assets in domestic gateway markets.

About WGS GeneDx Holdings Corp.

GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.

Share on Social Networks: